Qserve / Axon EU MDR and IVDR pop-up conference in Boston MA on 18 July

Qserve logoAXON_LOGO_CMYK kopie

Qserve Group and Axon Lawyers (my law firm) are organizing a pop-up mini conference about the new EU Medical Devices (MDR) and IVD Regulations (IVDR) at Qserve’s Boston MA office in the US on 18 July.

Qserve’s board member Gert Bos and Axon Lawyers’ partner Erik Vollebregt (that’s me) will provide a six and a half hours audience adjusted program to the discuss latest developments in EU medical devices and IVD regulation as well as offer practical advice about what a company should do to be compliant with the new regulations that apply as of 26 May 2020 and 2022 respectively.

This conference plans for active audience participation and is your unique opportunity to ask any outstanding questions that you may have. You will receive immediate practical advice and be updated on the latest developments by two of the foremost experts in the field of EU medical devices regulation. It’s rare to find this kind of hands on practical knowledge transfer regarding EU medical devices and IVD law in the US.

If you participate we invite you to send in specific questions ahead of the conference so we can adjust the program to the audience’s questions and needs.

Space is limited, so be sure to RSVP timely. Timely RSVP will also allow us to switch to a larger venue if needed and still possible.

Time: 18 July 2019, 9am to 3.30 pm – lunch is provided and included

Venue: Qserve (BNY Mellon Building), One Boston Place, 201 Washington Street, 6th floor, Boston, MA 02108

Investment: $ 395

RSVP and more information: erik.vollebregt@axonlawyers.com


Navigate through our knowledgebase

Related articles

Article

New sort of applicable economic operators regulation: the Market Surveillance Regulation

Attentive attendees of my presentations will have remarked in my presentations about economic operators that essential parts of the general Goods Package were being amended and that this may affect companies in…

Read more

Article

Transparency vs. Confidentiality: EFSA’s new role as from March 2021

Last month, the European Council formally adopted the new Regulation on the transparency of the EU risk assessment in the food chain, which will be applicable as of 26 March 2021. As is in the name, the new provisions aim at increased transparency of EU risk assessment, which for a large deal means strengthening the […]

Article

€ 500 per data subject – a quantification of why GDPR matters

Clients often ask me why they should invest in General Data Protection Regulation (GDPR) compliance so much. For medical devices and medicines regulatory compliance, they get it to an extent. Non-compliant devices…

Read more